BRCA1 and neoplasm: In our cohort, multivariate logistic regression using the unmatched dataset (N = 411) showed that BRCA1/2 mutation status, tumor size > 5 cm, ER-negative tumor, and the use of carboplatin-containing regimens were independently associated with achieving pCR.